Business context and reporting period
Filing identity: The request identifies Chiron Real Estate Inc., but the supplied filing is for Global Medical REIT Inc. This summary reflects the filing text. It is an unaudited Form 10-Q for the three months ended March 31, 2017, compared with the three months ended March 31, 2016.
Global Medical REIT acquires healthcare properties and leases them primarily to healthcare operators, generally under triple-net leases. The company reported completing eight property acquisitions during Q1 2017 and had 22 acquisitions in its portfolio as of March 31, 2017. It completed its IPO in July 2016.
Financial results and position
| Metric | Q1 2017 / March 31, 2017 | Prior comparable period / December 31, 2016 |
|---|---|---|
| Total revenue | $4.66 million | $1.31 million |
| Net loss | $2.54 million | $1.95 million loss |
| Net loss per share | $0.14 | $3.11 |
| FFO | $0.86 million loss; $(0.05) per share | $1.55 million loss; $(2.48) per share |
| AFFO | $0.28 million; $0.02 per share | $0.75 million loss; $(1.21) per share |
| Cash from operating activities | $0.82 million provided | $1.12 million used |
| Cash used in investing activities | $109.25 million | $37.57 million |
| Cash from financing activities | $97.12 million | $30.01 million |
| Cash and cash equivalents | $8.36 million | $19.67 million at Dec. 31, 2016 |
| Total assets | $325.77 million | $227.32 million at Dec. 31, 2016 |
| Total liabilities | $176.51 million | $72.29 million at Dec. 31, 2016 |
| Stockholders’ equity | $149.25 million | $155.03 million at Dec. 31, 2016 |
Revenue increased by $3.34 million year over year, principally from properties acquired after Q1 2016 and a full quarter of contribution from certain 2016 acquisitions. Net loss widened in dollars as operating costs rose with portfolio growth. The filing attributes year-over-year comparisons chiefly to the larger portfolio; weighted-average shares also rose sharply, from 624,978 to 17.61 million, following the IPO, making per-share comparisons less directly comparable.
Operating cash flow improved to positive $0.82 million, with management citing, among other factors, higher tenant security deposits and payables/accruals. Investing outflows reflected the eight acquisitions. Cash fell by $11.31 million during the quarter, mainly due to property purchases and dividends, partly offset by revolving-credit borrowings.
At March 31, debt included $128.90 million outstanding under the revolving credit facility and $39.47 million of acquisition-related notes, net of discount. The revolver commitment had been increased to $200 million, with a conditional $50 million accordion; borrowing availability is subject to a quarterly borrowing-base valuation. The $32.10 million Cantor loan bears fixed interest at 5.22% and matures in 2026; the $7.38 million West Mifflin note bears 3.72% and matures in 2020. The company reported $1.10 million of interest expense for Q1 2017. The filing does not provide a single stated total debt figure including all facility balances and related adjustments.
Material changes versus the prior period
- Eight Q1 acquisitions added approximately $108.1 million of acquired property and related assets. Net real estate investment rose to $294.1 million from $196.4 million at year-end 2016.
- Rental revenue increased to $4.63 million from $1.30 million. General and administrative expense rose to $2.84 million from $0.89 million; depreciation increased to $1.35 million from $0.40 million; and acquisition-related amortization was $0.34 million versus none in Q1 2016.
- Interest expense declined modestly, to $1.10 million from $1.13 million, as prior related-party and certain property debt had been repaid, partly offset by current-period costs on the Cantor loan and revolver.
- Revolver borrowings increased by $101.2 million during the quarter, from $27.7 million at year-end 2016 to $128.9 million.
- The quarterly dividend was $0.20 per common share, accrued at March 31 and paid April 10, 2017. The company paid $3.60 million of dividends in Q1, relating to the prior-quarter dividend.
Outlook, commentary, risks and unusual items
Management provided no quantitative earnings, revenue, acquisition, or distribution guidance. It said it intended to pursue additional acquisitions as suitable opportunities and financing became available, but noted there was no assurance that potential transactions would be completed. Management identified healthcare expenditure growth, aging demographics, and the shift toward outpatient care as potentially favorable trends; reimbursement changes, competition, and increased regulatory scrutiny could adversely affect tenants and rent collection.
The company said it expected to meet short-term liquidity needs with cash, operating cash flow, and financing sources, including the revolver and possible securities offerings. A universal shelf registration filed April 18, 2017 permits offers of up to $500 million of securities. The company’s ability to fund acquisitions and distributions depends on cash flows, borrowing capacity, access to capital, and compliance with debt covenants. It must distribute at least 90% of REIT taxable income to maintain REIT status.
Control weakness: Management concluded disclosure controls and procedures were not effective as of March 31, 2017 because a previously identified material weakness—insufficient segregation of duties—had not been remediated. Management reported adding personnel and engaging an independent consultant to review controls; it cautioned that remediation may be insufficient and that future financial statements could require material adjustments.
The filing reported no material litigation, no known material environmental liability, and no material change to previously disclosed risk factors. Subsequent events included the April 21 acquisition of a remaining Sandusky property for approximately $1.1 million and May changes in senior legal personnel and related equity awards.
Key investor verification points
- Confirm the filing issuer: the supplied document is Global Medical REIT Inc., not Chiron Real Estate Inc.
- Review acquisition economics, tenant/operator credit, lease guarantees, and the preliminary purchase-price allocations, which remain subject to revision.
- Verify revolver availability under the borrowing base and monitor leverage, fixed-charge coverage, and other covenant compliance as debt-funded acquisitions continue.
- Assess whether operating cash generation and AFFO can support the dividend, given the quarterly cash dividend and continued acquisition and financing needs.
- Track remediation of the material weakness in internal controls and any resulting adjustments or auditor conclusions.
- Examine tenant concentration and healthcare reimbursement exposure; HealthSouth facilities represented about 30% of Q1 rental revenue, while Omaha and Plano each represented about 9%.
- Review REIT qualification, related-party management fees, and the company’s use of non-GAAP FFO and AFFO, which may not be comparable with other REITs.